Welcome to UK Cell Therapy Group
where hope meets innovation in the fight against cancer.
Our Mission
Welcome to UK Cell Therapy, where hope meets innovation in the fight against cancer.
We understand that facing cancer can be one of the most daunting challenges anyone can encounter. It can be a journey fraught with uncertainty, fear, and countless questions about the best path forward. Amidst the overwhelming array of therapies available, we stand committed to simplifying your options and providing clarity in your journey towards healing.
At UK Cell Therapy, our passion lies in offering state-of-the-art cellular immunology treatments, meticulously designed to offer you the very highest quality care possible. We recognise that each patient's battle with cancer is unique, which is why our team of experts is dedicated to tailoring personalised solutions to meet your specific needs.
Our Treatments
Our treatments adhere to the strictest European regulations, ensuring safety and efficacy every step of the way with a multidisciplinary team of highly qualified Doctors, Nurses, Scientists, and Biologists, all driven by a shared commitment to excellence in cancer research, care & education. But beyond our cutting-edge treatments and regulatory compliance, what truly sets us apart is our unwavering empathy and understanding. We know the challenges that you face because we've seen them firsthand, and we're here to walk alongside you, offering support, guidance, and hope every step of the way.
Our therapies are utilised for the treatment of various types of cancer, such as:
Breast Cancer
Affecting primarily women, breast cancer is the most common cancer globally, comprising about 11.7% of all cancer cases. Immunotherapy, has shown promise in treating certain subtypes of breast cancer, offering new avenues for targeted therapy.
Bowel Cancer
Affecting both men and women, bowel cancer ranks third globally in terms of cancer incidence. Immunotherapy has shown efficacy in treating advanced stages of bowel cancer, particularly in cases with high microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR).
Liver Cancer
More prevalent in men than in women, liver cancer is the sixth most common cancer worldwide. Immunotherapy has demonstrated effectiveness in treating advanced liver cancer, offering new hope for patients with limited treatment options.
Blood Cancer
Blood cancers, including leukemia, lymphoma, and myeloma, affect people of all ages and genders. Immunotherapy has revolutionised the treatment landscape for certain blood cancers, such as Hodgkin's lymphoma and some types of leukemia, providing durable responses and improving outcomes.
Pancreatic cancer
Pancreatic cancer, though comprising only about 3% of all cancers, is one of the deadliest with a five-year survival rate of around 10% globally. It disproportionately affects older individuals, with the median age at diagnosis being 70 years, and is slightly more common in men. Immunotherapy has shown strong results, offering new hope in the fight against this aggressive disease.
Lung Cancer
Primarily affecting smokers and former smokers, lung cancer is the leading cause of cancer-related deaths globally. Immunotherapy has emerged as a breakthrough treatment option for advanced lung cancer, particularly in patients with high programmed death-ligand 1 (PD-L1) expression, extending survival rates and improving quality of life.
Brain & Spine Cancer
Brain and spine cancers can affect individuals of all ages, although certain types are more common in children and young adults. Ongoing research aims to unlock its potential in this challenging area of oncology.
Bone Cancer
Bone cancer, including primary bone tumors and metastatic bone disease, can occur at any age but is more prevalent in children and adolescents.
Prostate Cancer
Primarily affecting older men, prostate cancer is the second most common cancer in men worldwide. Ongoing research seeks to enhance its effectiveness, particularly in combination with other treatment modalities.
Skin Cancer
Skin cancer, including melanoma and non-melanoma skin cancers like basal cell carcinoma and squamous cell carcinoma, affects individuals of all ages, with higher incidence rates in fair-skinned populations. Immunotherapy has revolutionised the treatment of advanced melanoma, significantly improving survival rates and offering long-term remission possibilities.
We can provide individualised
therapy no matter where you are.
Our Home
UK Cell Therapy Group Limited
Magdalen Centre
Oxford Science Park
Robert Robinson Avenue
Oxford
OX4 4GA
Contact Us
0345 565 3104
enquiries@ukcelltherapy.co.uk